comparemela.com

Latest Breaking News On - திசு ரேகேனீக்ஷ - Page 3 : comparemela.com

Investegate |Tissue Regenix Group Announcements | Tissue Regenix Group: Director/PDMR Shareholding

Investegate |Tissue Regenix Group Announcements | Tissue Regenix Group: Director/PDMR Shareholding
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Investegate |Tissue Regenix Group Announcements | Tissue Regenix Group: Result of AGM

A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;

Investegate |Tissue Regenix Group Announcements | Tissue Regenix Group: Director/PDMR Shareholding

A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;

Tissue Regenix Group PLC confident on post-pandemic prospects

Tissue Regenix confident on post-COVID-19 prospects The capacity expansion programme will alleviate the supply issues that have previously hindered growth and will provide a step-change in the business trajectory, the firm said Tissue Regenix Group PLC (LON:TRX) said it is confident in its prospects once the Coronavirus (COVID-19) pandemic subsides and healthcare procedures return to a normalised level. The medical technology company has entered the UK and specific EU markets with OrthoPure XT and established white label manufacturing capabilities with a large global partner. The capacity expansion programme will alleviate the supply issues that have previously hindered growth and will provide a step-change in the business trajectory, as the firm secures additional distribution contracts and increases its geographic outreach.

Investegate | Company News | Corporate, London Stock Exchange, Regulatory News Headlines Tissue Regenix losses deepen on impairment charge; lower sales

A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.